Blood test could predict melanoma treatment resistance
NCT ID NCT04866680
Summary
This study is testing whether analyzing tumor DNA found in blood can help doctors predict when melanoma treatments might stop working. It involves 136 patients with stage IIB-IV melanoma who have had surgery and are receiving standard follow-up treatments. Researchers will track DNA levels in blood samples to see if changes predict treatment resistance before it becomes clinically apparent.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CGFL
Dijon, France
-
CHU Jean Minjoz
Besançon, France
-
Chru Lille
Lille, France
-
Chru Nancy
Vandœuvre-lès-Nancy, France
-
Chu Dijon
Dijon, France
-
Ghr Mulhouse Sud Alsace
Mulhouse, France
-
Institut Godinot
Reims, 51100, France
-
Institut de Cancerologie de Lorraine
Vandœuvre-lès-Nancy, 54519, France
Conditions
Explore the condition pages connected to this study.